250 related articles for article (PubMed ID: 34413309)
1. Genome dependent Cas9/gRNA search time underlies sequence dependent gRNA activity.
Moreb EA; Lynch MD
Nat Commun; 2021 Aug; 12(1):5034. PubMed ID: 34413309
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting Rates.
Moreb EA; Hutmacher M; Lynch MD
CRISPR J; 2020 Dec; 3(6):550-561. PubMed ID: 33346713
[TBL] [Abstract][Full Text] [Related]
3. gRNA validation for wheat genome editing with the CRISPR-Cas9 system.
Arndell T; Sharma N; Langridge P; Baumann U; Watson-Haigh NS; Whitford R
BMC Biotechnol; 2019 Oct; 19(1):71. PubMed ID: 31684940
[TBL] [Abstract][Full Text] [Related]
4. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
Zhu LJ; Holmes BR; Aronin N; Brodsky MH
PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
[TBL] [Abstract][Full Text] [Related]
5. A method to convert mRNA into a gRNA library for CRISPR/Cas9 editing of any organism.
Arakawa H
Sci Adv; 2016 Aug; 2(8):e1600699. PubMed ID: 27574704
[TBL] [Abstract][Full Text] [Related]
6. WheatCRISPR: a web-based guide RNA design tool for CRISPR/Cas9-mediated genome editing in wheat.
Cram D; Kulkarni M; Buchwaldt M; Rajagopalan N; Bhowmik P; Rozwadowski K; Parkin IAP; Sharpe AG; Kagale S
BMC Plant Biol; 2019 Nov; 19(1):474. PubMed ID: 31694550
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.
Mekler V; Kuznedelov K; Severinov K
J Biol Chem; 2020 May; 295(19):6509-6517. PubMed ID: 32241913
[TBL] [Abstract][Full Text] [Related]
8. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
9. Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity.
Höijer I; Johansson J; Gudmundsson S; Chin CS; Bunikis I; Häggqvist S; Emmanouilidou A; Wilbe M; den Hoed M; Bondeson ML; Feuk L; Gyllensten U; Ameur A
Genome Biol; 2020 Dec; 21(1):290. PubMed ID: 33261648
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 gRNA activity depends on free energy changes and on the target PAM context.
Corsi GI; Qu K; Alkan F; Pan X; Luo Y; Gorodkin J
Nat Commun; 2022 May; 13(1):3006. PubMed ID: 35637227
[TBL] [Abstract][Full Text] [Related]
11. Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing.
Li J; Wu P; Cao Z; Huang G; Lu Z; Yan J; Zhang H; Zhou Y; Liu R; Chen H; Ma L; Luo M
Cell Rep; 2024 Feb; 43(2):113765. PubMed ID: 38358884
[TBL] [Abstract][Full Text] [Related]
12. DeepCRISTL: deep transfer learning to predict CRISPR/Cas9 functional and endogenous on-target editing efficiency.
Elkayam S; Orenstein Y
Bioinformatics; 2022 Jun; 38(Suppl 1):i161-i168. PubMed ID: 35758815
[TBL] [Abstract][Full Text] [Related]
13. Determinants for Efficient Editing with Cas9-Mediated Recombineering in
Choudhury A; Fankhauser RG; Freed EF; Oh EJ; Morgenthaler AB; Bassalo MC; Copley SD; Kaar JL; Gill RT
ACS Synth Biol; 2020 May; 9(5):1083-1099. PubMed ID: 32298586
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 off-targeting assessment with nucleic acid duplex energy parameters.
Alkan F; Wenzel A; Anthon C; Havgaard JH; Gorodkin J
Genome Biol; 2018 Oct; 19(1):177. PubMed ID: 30367669
[TBL] [Abstract][Full Text] [Related]
15. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
[TBL] [Abstract][Full Text] [Related]
16. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
Wang Q; Ui-Tei K
Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
[TBL] [Abstract][Full Text] [Related]
17. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
Riesenberg S; Helmbrecht N; Kanis P; Maricic T; Pääbo S
Nat Commun; 2022 Jan; 13(1):489. PubMed ID: 35078986
[TBL] [Abstract][Full Text] [Related]
18. Development of a gRNA Expression and Processing Platform for Efficient CRISPR-Cas9-Based Gene Editing and Gene Silencing in Candida tropicalis.
Li Y; Zhang L; Yang H; Xia Y; Liu L; Chen X; Shen W
Microbiol Spectr; 2022 Jun; 10(3):e0005922. PubMed ID: 35543560
[TBL] [Abstract][Full Text] [Related]
19. A catalogue of biochemically diverse CRISPR-Cas9 orthologs.
Gasiunas G; Young JK; Karvelis T; Kazlauskas D; Urbaitis T; Jasnauskaite M; Grusyte MM; Paulraj S; Wang PH; Hou Z; Dooley SK; Cigan M; Alarcon C; Chilcoat ND; Bigelyte G; Curcuru JL; Mabuchi M; Sun Z; Fuchs RT; Schildkraut E; Weigele PR; Jack WE; Robb GB; Venclovas Č; Siksnys V
Nat Commun; 2020 Nov; 11(1):5512. PubMed ID: 33139742
[TBL] [Abstract][Full Text] [Related]
20. multicrispr: gRNA design for prime editing and parallel targeting of thousands of targets.
Bhagwat AM; Graumann J; Wiegandt R; Bentsen M; Welker J; Kuenne C; Preussner J; Braun T; Looso M
Life Sci Alliance; 2020 Nov; 3(11):. PubMed ID: 32907859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
